Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual testosterone versus placebo in premenopausal women with hypoactive sexual desire disorder
NL-OMON34740Phase 2Active, not recruiting
- Sponsor
- Emotional Brain
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of testosterone in hypoactive sexual desire disorder (HSDD) and female sexual dysfunction (FSD) (2 arms), sponsored by Emotional Brain. Primary endpoints: Vaginal Pulse Amplitude and SARSAQ questionnaire. Started May 2010; status: active, not recruiting.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NL-OMON34740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34740.